Celldex Therapeutics, Inc.

Nasdaq:CLDX

In Vitro & In Vivo Diagnostic Substances·HAMPTON, NJ

Governanceproxy statements · beneficial ownership

Proxy Statements

23 shown

Filed	Form	Description
4/21/25	DEF 14A	DEF 14A	→
4/25/24	DEF 14A	DEF 14A	→
4/25/23	DEF 14A	DEF 14A	→
4/26/22	DEF 14A	DEF 14A	→
4/27/21	DEF 14A	DEF 14A	→
4/28/20	DEF 14A	DEF 14A	→
↓

Ownership Filings

40 shown

Filed	Form	Description
1/6/26	4	4	→
12/17/25	4	4	→
12/8/25	4	4	→
11/17/25	4	4	→
11/12/25	4	4	→
11/12/25	3	3	→
↓